Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03041493 · ClinicalTrials.gov registry record · NA
Investigation of the Effects of Electronic Cigarettes on Vascular Health
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03041493: Clinical Trial NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03041493 is a NA study that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03041493, a NA study, was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The goal is find out if the use of Electronic cigarettes (EC) leads to the same changes that we see in blood vessels of traditional cigarettes (TC) users. The investigators will also enroll non-smokers as "controls", against which they will measure changes in blood vessels in TC and EC users.
Interventions
- BEHAVIORAL Electronic cigarette
- BEHAVIORAL traditional cigarette
- BEHAVIORAL (sham cigarette) - no actual exposure to cigarettes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2017-02-01 |
| Est. Completion | 2021-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03041493
The ClinicalTrials.gov registry entry for NCT03041493 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Electronic cigarette is the first listed.
NCT03041493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03041493 about?
NCT03041493 is a clinical study titled "Investigation of the Effects of Electronic Cigarettes on Vascular Health". The goal is find out if the use of Electronic cigarettes (EC) leads to the same changes that we see in blood vessels of traditional cigarettes (TC) users. The investigators will also enroll non-smokers as "controls", against which they will measure changes in blood vessels in TC and EC users.
What is the current status of trial NCT03041493?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2017-02-01. Estimated completion is 2021-06-11.
What interventions are being tested in trial NCT03041493?
The interventions under investigation include: Electronic cigarette (BEHAVIORAL), traditional cigarette (BEHAVIORAL), (sham cigarette) - no actual exposure to cigarettes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03041493?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.